{"bundle_type":"pith_open_graph_bundle","bundle_version":"1.0","pith_number":"pith:2026:BFXEJFEVNK5HQO5SYB3DOSIW7H","short_pith_number":"pith:BFXEJFEV","canonical_record":{"source":{"id":"2605.17313","kind":"arxiv","version":1},"metadata":{"license":"http://creativecommons.org/licenses/by/4.0/","primary_cat":"q-bio.PE","submitted_at":"2026-05-17T08:07:00Z","cross_cats_sorted":[],"title_canon_sha256":"6dceb668d68b730dc4cd2f7872343865ea54777ea9ecde0c3863b7b679351296","abstract_canon_sha256":"9aee3f12354759104edf039d8f849a277483eaf21144ad1875d4544479692836"},"schema_version":"1.0"},"canonical_sha256":"096e4494956aba783bb2c076374916f9fa8956ab9474c1dd26ceea3b879b66d9","source":{"kind":"arxiv","id":"2605.17313","version":1},"source_aliases":[{"alias_kind":"arxiv","alias_value":"2605.17313","created_at":"2026-05-20T00:03:51Z"},{"alias_kind":"arxiv_version","alias_value":"2605.17313v1","created_at":"2026-05-20T00:03:51Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.2605.17313","created_at":"2026-05-20T00:03:51Z"},{"alias_kind":"pith_short_12","alias_value":"BFXEJFEVNK5H","created_at":"2026-05-20T00:03:51Z"},{"alias_kind":"pith_short_16","alias_value":"BFXEJFEVNK5HQO5S","created_at":"2026-05-20T00:03:51Z"},{"alias_kind":"pith_short_8","alias_value":"BFXEJFEV","created_at":"2026-05-20T00:03:51Z"}],"events":[{"event_type":"record_created","subject_pith_number":"pith:2026:BFXEJFEVNK5HQO5SYB3DOSIW7H","target":"record","payload":{"canonical_record":{"source":{"id":"2605.17313","kind":"arxiv","version":1},"metadata":{"license":"http://creativecommons.org/licenses/by/4.0/","primary_cat":"q-bio.PE","submitted_at":"2026-05-17T08:07:00Z","cross_cats_sorted":[],"title_canon_sha256":"6dceb668d68b730dc4cd2f7872343865ea54777ea9ecde0c3863b7b679351296","abstract_canon_sha256":"9aee3f12354759104edf039d8f849a277483eaf21144ad1875d4544479692836"},"schema_version":"1.0"},"canonical_sha256":"096e4494956aba783bb2c076374916f9fa8956ab9474c1dd26ceea3b879b66d9","receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-05-20T00:03:51.659745Z","signature_b64":"g7Wx+P0m/DodxVQXW0tlEYybDCruoc9+BbV58bCz9iDRCh7Ls5eKxxnvKkTSO3ba4TBjgTIse9Nebot6McYODg==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"096e4494956aba783bb2c076374916f9fa8956ab9474c1dd26ceea3b879b66d9","last_reissued_at":"2026-05-20T00:03:51.658813Z","signature_status":"signed_v1","first_computed_at":"2026-05-20T00:03:51.658813Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"source_kind":"arxiv","source_id":"2605.17313","source_version":1,"attestation_state":"computed"},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-05-20T00:03:51Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"uA62CPQNREVlsLOROkNrMRbBrbHRbstneUOaKg0eyXDXwPEy+8cwjoEAHjAPdaR3wfSRy8XzkMFvI92bNeSbAg==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-05-21T16:43:11.844764Z"},"content_sha256":"4e5e57573dfb238088a5d90ba393b3883d456dc8300c8805accc0e1228d906b7","schema_version":"1.0","event_id":"sha256:4e5e57573dfb238088a5d90ba393b3883d456dc8300c8805accc0e1228d906b7"},{"event_type":"graph_snapshot","subject_pith_number":"pith:2026:BFXEJFEVNK5HQO5SYB3DOSIW7H","target":"graph","payload":{"graph_snapshot":{"paper":{"title":"Dose-limited interventions in an epidemiological model","license":"http://creativecommons.org/licenses/by/4.0/","headline":"Limited treatment doses in an SLIARS model typically reduce to either having none or to the standard case with vaccination and treatment.","cross_cats":[],"primary_cat":"q-bio.PE","authors_text":"Annour Saad Abdramane, Hippolyte Djimramadji, Julien Arino, Mahamat Saleh Daoussa Haggar, Patrick Mimphis Tchepmo Djomegni","submitted_at":"2026-05-17T08:07:00Z","abstract_excerpt":"We consider an SLIARS mathematical epidemiology model including intervention in the form of vaccination and treatment. Contrary to classical models, it is assumed that treatment doses can be limited in availability. Mathematically, we show that most scenarios actually reduce to classic well-known scenarios: having an unreplenished number of doses is akin to having none, while being able to restore stocks is (often) equivalent to the classic situation with vaccination and treatment. We also perform a computational analysis, illustrating some of the transient and stochastic dynamics that diverge"},"claims":{"count":4,"items":[{"kind":"strongest_claim","text":"Most scenarios actually reduce to classic well-known scenarios: having an unreplenished number of doses is akin to having none, while being able to restore stocks is (often) equivalent to the classic situation with vaccination and treatment.","source":"verdict.strongest_claim","status":"machine_extracted","claim_id":"C1","attestation":"unclaimed"},{"kind":"weakest_assumption","text":"The specific structure of the SLIARS model and the mathematical formulation of dose limitation allow the claimed reductions to classic cases; this equivalence may fail if the dose dynamics or intervention timing differ from the modeled assumptions.","source":"verdict.weakest_assumption","status":"machine_extracted","claim_id":"C2","attestation":"unclaimed"},{"kind":"one_line_summary","text":"Limited treatment doses in an SLIARS model reduce to classic no-dose or unlimited-dose scenarios, with analysis of transient, stochastic, and budgetary dynamics.","source":"verdict.one_line_summary","status":"machine_extracted","claim_id":"C3","attestation":"unclaimed"},{"kind":"headline","text":"Limited treatment doses in an SLIARS model typically reduce to either having none or to the standard case with vaccination and treatment.","source":"verdict.pith_extraction.headline","status":"machine_extracted","claim_id":"C4","attestation":"unclaimed"}],"snapshot_sha256":"f321f6b0721941a0ed98990acd1e2dc223baf7d4c0dcf3d206b1351375be9564"},"source":{"id":"2605.17313","kind":"arxiv","version":1},"verdict":{"id":"c96c34b1-7302-47dd-a5c2-4dad96478aa0","model_set":{"reader":"grok-4.3"},"created_at":"2026-05-19T22:56:32.917693Z","strongest_claim":"Most scenarios actually reduce to classic well-known scenarios: having an unreplenished number of doses is akin to having none, while being able to restore stocks is (often) equivalent to the classic situation with vaccination and treatment.","one_line_summary":"Limited treatment doses in an SLIARS model reduce to classic no-dose or unlimited-dose scenarios, with analysis of transient, stochastic, and budgetary dynamics.","pipeline_version":"pith-pipeline@v0.9.0","weakest_assumption":"The specific structure of the SLIARS model and the mathematical formulation of dose limitation allow the claimed reductions to classic cases; this equivalence may fail if the dose dynamics or intervention timing differ from the modeled assumptions.","pith_extraction_headline":"Limited treatment doses in an SLIARS model typically reduce to either having none or to the standard case with vaccination and treatment."},"integrity":{"clean":true,"summary":{"advisory":0,"critical":0,"by_detector":{},"informational":0},"endpoint":"/pith/2605.17313/integrity.json","findings":[],"available":true,"detectors_run":[{"name":"doi_compliance","ran_at":"2026-05-19T23:01:52.428209Z","status":"completed","version":"1.0.0","findings_count":0},{"name":"doi_title_agreement","ran_at":"2026-05-19T23:01:19.687888Z","status":"completed","version":"1.0.0","findings_count":0},{"name":"claim_evidence","ran_at":"2026-05-19T22:01:57.785038Z","status":"completed","version":"1.0.0","findings_count":0},{"name":"ai_meta_artifact","ran_at":"2026-05-19T21:33:23.753251Z","status":"skipped","version":"1.0.0","findings_count":0}],"snapshot_sha256":"863031bce5743f10dd507b4a63035823a05d16657dee9b5eab6f6908295261e1"},"references":{"count":30,"sample":[{"doi":"","year":2021,"title":"Acharya K. P., Ghimire T. R., and Subramanya S. H. Access to and equitable distribution of COVID-19 vaccine in low-income countries.npj Vaccines, 6(1):54, 2021","work_id":"0098f976-9b6b-4f8b-afde-e60b46635514","ref_index":1,"cited_arxiv_id":"","is_internal_anchor":false},{"doi":"","year":2012,"title":"Cost-effectiveness of using a two-dose measles vaccine schedule","work_id":"b3478275-2a61-470b-b623-e511ab672bde","ref_index":3,"cited_arxiv_id":"","is_internal_anchor":false},{"doi":"","year":2021,"title":"M., Vassall A., and Gomez G","work_id":"7e1606b3-b9f7-42a7-87db-a49c1fbcde60","ref_index":4,"cited_arxiv_id":"","is_internal_anchor":false},{"doi":"","year":2023,"title":"Dimitrova A., Carrasco-Escobar G., Richardson R., and Benmarhnia T. Essential childhood im- munization in 43 low-and middle-income countries: Analysis of spatial trends and socioeconomic inequalities ","work_id":"78201906-7fe5-412b-ae00-80b24998bf4a","ref_index":5,"cited_arxiv_id":"","is_internal_anchor":false},{"doi":"","year":2018,"title":"Duijzer L. E., vanJaarsveld W. L., Wallinga J., and Dekker R. Dose-optimal vaccine allocation over multiple populations.Production and Operations Management, 27(1):143–159, 2018","work_id":"02f6e77e-be07-4823-8db1-47aa30694ff1","ref_index":6,"cited_arxiv_id":"","is_internal_anchor":false}],"resolved_work":30,"snapshot_sha256":"4cf6f552e25a2038e4b785af646ff081dd425d4c47b79067a1c1686428a4cc6d","internal_anchors":0},"formal_canon":{"evidence_count":1,"snapshot_sha256":"c8839b96e3c9b5c272a6f7c99a62bcc1186171c6d0ebcaa676f6548a1e3ba8bf"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"verdict_id":"c96c34b1-7302-47dd-a5c2-4dad96478aa0"},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-05-20T00:03:51Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"OWYhK7DOY+SddzinFSOeb0gDmzuwigDkq0LQMHpIJnJB4tbcEmlJljYAjMD+7nZHm7/225kNH5DLaUCUu0KeDA==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-05-21T16:43:11.846044Z"},"content_sha256":"bc107f9e252dbb060fb870f854ab1b8d9b92b15523c062b5a4f65d7e2efcb282","schema_version":"1.0","event_id":"sha256:bc107f9e252dbb060fb870f854ab1b8d9b92b15523c062b5a4f65d7e2efcb282"}],"timestamp_proofs":[],"mirror_hints":[{"mirror_type":"https","name":"Pith Resolver","base_url":"https://pith.science","bundle_url":"https://pith.science/pith/BFXEJFEVNK5HQO5SYB3DOSIW7H/bundle.json","state_url":"https://pith.science/pith/BFXEJFEVNK5HQO5SYB3DOSIW7H/state.json","well_known_bundle_url":"https://pith.science/.well-known/pith/BFXEJFEVNK5HQO5SYB3DOSIW7H/bundle.json","status":"primary"}],"public_keys":[{"key_id":"pith-v1-2026-05","algorithm":"ed25519","format":"raw","public_key_b64":"stVStoiQhXFxp4s2pdzPNoqVNBMojDU/fJ2db5S3CbM=","public_key_hex":"b2d552b68890857171a78b36a5dccf368a953413288c353f7c9d9d6f94b709b3","fingerprint_sha256_b32_first128bits":"RVFV5Z2OI2J3ZUO7ERDEBCYNKS","fingerprint_sha256_hex":"8d4b5ee74e4693bcd1df2446408b0d54","rotates_at":null,"url":"https://pith.science/pith-signing-key.json","notes":"Pith uses this Ed25519 key to sign canonical record SHA-256 digests. Verify with: ed25519_verify(public_key, message=canonical_sha256_bytes, signature=base64decode(signature_b64))."}],"merge_version":"pith-open-graph-merge-v1","built_at":"2026-05-21T16:43:11Z","links":{"resolver":"https://pith.science/pith/BFXEJFEVNK5HQO5SYB3DOSIW7H","bundle":"https://pith.science/pith/BFXEJFEVNK5HQO5SYB3DOSIW7H/bundle.json","state":"https://pith.science/pith/BFXEJFEVNK5HQO5SYB3DOSIW7H/state.json","well_known_bundle":"https://pith.science/.well-known/pith/BFXEJFEVNK5HQO5SYB3DOSIW7H/bundle.json"},"state":{"state_type":"pith_open_graph_state","state_version":"1.0","pith_number":"pith:2026:BFXEJFEVNK5HQO5SYB3DOSIW7H","merge_version":"pith-open-graph-merge-v1","event_count":2,"valid_event_count":2,"invalid_event_count":0,"equivocation_count":0,"current":{"canonical_record":{"metadata":{"abstract_canon_sha256":"9aee3f12354759104edf039d8f849a277483eaf21144ad1875d4544479692836","cross_cats_sorted":[],"license":"http://creativecommons.org/licenses/by/4.0/","primary_cat":"q-bio.PE","submitted_at":"2026-05-17T08:07:00Z","title_canon_sha256":"6dceb668d68b730dc4cd2f7872343865ea54777ea9ecde0c3863b7b679351296"},"schema_version":"1.0","source":{"id":"2605.17313","kind":"arxiv","version":1}},"source_aliases":[{"alias_kind":"arxiv","alias_value":"2605.17313","created_at":"2026-05-20T00:03:51Z"},{"alias_kind":"arxiv_version","alias_value":"2605.17313v1","created_at":"2026-05-20T00:03:51Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.2605.17313","created_at":"2026-05-20T00:03:51Z"},{"alias_kind":"pith_short_12","alias_value":"BFXEJFEVNK5H","created_at":"2026-05-20T00:03:51Z"},{"alias_kind":"pith_short_16","alias_value":"BFXEJFEVNK5HQO5S","created_at":"2026-05-20T00:03:51Z"},{"alias_kind":"pith_short_8","alias_value":"BFXEJFEV","created_at":"2026-05-20T00:03:51Z"}],"graph_snapshots":[{"event_id":"sha256:bc107f9e252dbb060fb870f854ab1b8d9b92b15523c062b5a4f65d7e2efcb282","target":"graph","created_at":"2026-05-20T00:03:51Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"graph_snapshot":{"author_claims":{"count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","strong_count":0},"builder_version":"pith-number-builder-2026-05-17-v1","claims":{"count":4,"items":[{"attestation":"unclaimed","claim_id":"C1","kind":"strongest_claim","source":"verdict.strongest_claim","status":"machine_extracted","text":"Most scenarios actually reduce to classic well-known scenarios: having an unreplenished number of doses is akin to having none, while being able to restore stocks is (often) equivalent to the classic situation with vaccination and treatment."},{"attestation":"unclaimed","claim_id":"C2","kind":"weakest_assumption","source":"verdict.weakest_assumption","status":"machine_extracted","text":"The specific structure of the SLIARS model and the mathematical formulation of dose limitation allow the claimed reductions to classic cases; this equivalence may fail if the dose dynamics or intervention timing differ from the modeled assumptions."},{"attestation":"unclaimed","claim_id":"C3","kind":"one_line_summary","source":"verdict.one_line_summary","status":"machine_extracted","text":"Limited treatment doses in an SLIARS model reduce to classic no-dose or unlimited-dose scenarios, with analysis of transient, stochastic, and budgetary dynamics."},{"attestation":"unclaimed","claim_id":"C4","kind":"headline","source":"verdict.pith_extraction.headline","status":"machine_extracted","text":"Limited treatment doses in an SLIARS model typically reduce to either having none or to the standard case with vaccination and treatment."}],"snapshot_sha256":"f321f6b0721941a0ed98990acd1e2dc223baf7d4c0dcf3d206b1351375be9564"},"formal_canon":{"evidence_count":1,"snapshot_sha256":"c8839b96e3c9b5c272a6f7c99a62bcc1186171c6d0ebcaa676f6548a1e3ba8bf"},"integrity":{"available":true,"clean":true,"detectors_run":[{"findings_count":0,"name":"doi_compliance","ran_at":"2026-05-19T23:01:52.428209Z","status":"completed","version":"1.0.0"},{"findings_count":0,"name":"doi_title_agreement","ran_at":"2026-05-19T23:01:19.687888Z","status":"completed","version":"1.0.0"},{"findings_count":0,"name":"claim_evidence","ran_at":"2026-05-19T22:01:57.785038Z","status":"completed","version":"1.0.0"},{"findings_count":0,"name":"ai_meta_artifact","ran_at":"2026-05-19T21:33:23.753251Z","status":"skipped","version":"1.0.0"}],"endpoint":"/pith/2605.17313/integrity.json","findings":[],"snapshot_sha256":"863031bce5743f10dd507b4a63035823a05d16657dee9b5eab6f6908295261e1","summary":{"advisory":0,"by_detector":{},"critical":0,"informational":0}},"paper":{"abstract_excerpt":"We consider an SLIARS mathematical epidemiology model including intervention in the form of vaccination and treatment. Contrary to classical models, it is assumed that treatment doses can be limited in availability. Mathematically, we show that most scenarios actually reduce to classic well-known scenarios: having an unreplenished number of doses is akin to having none, while being able to restore stocks is (often) equivalent to the classic situation with vaccination and treatment. We also perform a computational analysis, illustrating some of the transient and stochastic dynamics that diverge","authors_text":"Annour Saad Abdramane, Hippolyte Djimramadji, Julien Arino, Mahamat Saleh Daoussa Haggar, Patrick Mimphis Tchepmo Djomegni","cross_cats":[],"headline":"Limited treatment doses in an SLIARS model typically reduce to either having none or to the standard case with vaccination and treatment.","license":"http://creativecommons.org/licenses/by/4.0/","primary_cat":"q-bio.PE","submitted_at":"2026-05-17T08:07:00Z","title":"Dose-limited interventions in an epidemiological model"},"references":{"count":30,"internal_anchors":0,"resolved_work":30,"sample":[{"cited_arxiv_id":"","doi":"","is_internal_anchor":false,"ref_index":1,"title":"Acharya K. P., Ghimire T. R., and Subramanya S. H. Access to and equitable distribution of COVID-19 vaccine in low-income countries.npj Vaccines, 6(1):54, 2021","work_id":"0098f976-9b6b-4f8b-afde-e60b46635514","year":2021},{"cited_arxiv_id":"","doi":"","is_internal_anchor":false,"ref_index":3,"title":"Cost-effectiveness of using a two-dose measles vaccine schedule","work_id":"b3478275-2a61-470b-b623-e511ab672bde","year":2012},{"cited_arxiv_id":"","doi":"","is_internal_anchor":false,"ref_index":4,"title":"M., Vassall A., and Gomez G","work_id":"7e1606b3-b9f7-42a7-87db-a49c1fbcde60","year":2021},{"cited_arxiv_id":"","doi":"","is_internal_anchor":false,"ref_index":5,"title":"Dimitrova A., Carrasco-Escobar G., Richardson R., and Benmarhnia T. Essential childhood im- munization in 43 low-and middle-income countries: Analysis of spatial trends and socioeconomic inequalities ","work_id":"78201906-7fe5-412b-ae00-80b24998bf4a","year":2023},{"cited_arxiv_id":"","doi":"","is_internal_anchor":false,"ref_index":6,"title":"Duijzer L. E., vanJaarsveld W. L., Wallinga J., and Dekker R. Dose-optimal vaccine allocation over multiple populations.Production and Operations Management, 27(1):143–159, 2018","work_id":"02f6e77e-be07-4823-8db1-47aa30694ff1","year":2018}],"snapshot_sha256":"4cf6f552e25a2038e4b785af646ff081dd425d4c47b79067a1c1686428a4cc6d"},"source":{"id":"2605.17313","kind":"arxiv","version":1},"verdict":{"created_at":"2026-05-19T22:56:32.917693Z","id":"c96c34b1-7302-47dd-a5c2-4dad96478aa0","model_set":{"reader":"grok-4.3"},"one_line_summary":"Limited treatment doses in an SLIARS model reduce to classic no-dose or unlimited-dose scenarios, with analysis of transient, stochastic, and budgetary dynamics.","pipeline_version":"pith-pipeline@v0.9.0","pith_extraction_headline":"Limited treatment doses in an SLIARS model typically reduce to either having none or to the standard case with vaccination and treatment.","strongest_claim":"Most scenarios actually reduce to classic well-known scenarios: having an unreplenished number of doses is akin to having none, while being able to restore stocks is (often) equivalent to the classic situation with vaccination and treatment.","weakest_assumption":"The specific structure of the SLIARS model and the mathematical formulation of dose limitation allow the claimed reductions to classic cases; this equivalence may fail if the dose dynamics or intervention timing differ from the modeled assumptions."}},"verdict_id":"c96c34b1-7302-47dd-a5c2-4dad96478aa0"}}],"author_attestations":[],"timestamp_anchors":[],"storage_attestations":[],"citation_signatures":[],"replication_records":[],"corrections":[],"mirror_hints":[],"record_created":{"event_id":"sha256:4e5e57573dfb238088a5d90ba393b3883d456dc8300c8805accc0e1228d906b7","target":"record","created_at":"2026-05-20T00:03:51Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"attestation_state":"computed","canonical_record":{"metadata":{"abstract_canon_sha256":"9aee3f12354759104edf039d8f849a277483eaf21144ad1875d4544479692836","cross_cats_sorted":[],"license":"http://creativecommons.org/licenses/by/4.0/","primary_cat":"q-bio.PE","submitted_at":"2026-05-17T08:07:00Z","title_canon_sha256":"6dceb668d68b730dc4cd2f7872343865ea54777ea9ecde0c3863b7b679351296"},"schema_version":"1.0","source":{"id":"2605.17313","kind":"arxiv","version":1}},"canonical_sha256":"096e4494956aba783bb2c076374916f9fa8956ab9474c1dd26ceea3b879b66d9","receipt":{"algorithm":"ed25519","builder_version":"pith-number-builder-2026-05-17-v1","canonical_sha256":"096e4494956aba783bb2c076374916f9fa8956ab9474c1dd26ceea3b879b66d9","first_computed_at":"2026-05-20T00:03:51.658813Z","key_id":"pith-v1-2026-05","kind":"pith_receipt","last_reissued_at":"2026-05-20T00:03:51.658813Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","receipt_version":"0.3","signature_b64":"g7Wx+P0m/DodxVQXW0tlEYybDCruoc9+BbV58bCz9iDRCh7Ls5eKxxnvKkTSO3ba4TBjgTIse9Nebot6McYODg==","signature_status":"signed_v1","signed_at":"2026-05-20T00:03:51.659745Z","signed_message":"canonical_sha256_bytes"},"source_id":"2605.17313","source_kind":"arxiv","source_version":1}}},"equivocations":[],"invalid_events":[],"applied_event_ids":["sha256:4e5e57573dfb238088a5d90ba393b3883d456dc8300c8805accc0e1228d906b7","sha256:bc107f9e252dbb060fb870f854ab1b8d9b92b15523c062b5a4f65d7e2efcb282"],"state_sha256":"67d0434bd03dc378a9c3b265bb2327c2ea90717de7c785942aef08278d2d8fa9"},"bundle_signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"/73xw84RwPuG/aw9baj1reVrtx8yjgiH+fkKP0ySlcYKLaGx33TE7Ye35ELWlVPf9i/+p5+8mGbJMfcD3VfZDQ==","signed_message":"bundle_sha256_bytes","signed_at":"2026-05-21T16:43:11.850905Z","bundle_sha256":"5c7d910ec209cc041542f9e4c55ff0e9c955a101c9ac12173aafdaec480305c4"}}